GDP: Questions & Answers about the Scope of the EU-GDP Guidelines
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The European GDP Association has recently updated its "Good Distribution Practices (GDP) - FAQs". In this second set of questions and answers, details about the scope are addressed. The following ambiguities are clarified:
Do the EU-GDP Guidelines apply for:
- Veterinary products?
- Investigational Medicinal Products (IMPs)?
- Active Pharmaceutical Products (APIs) and Excipients?
- Hubs?
But the issuance of official GDP certificates is also explained. It is pointed out that "transport companies do not need to hold a wholesale distribution authorisation to transport medicinal products". But, of course, they need to "follow the parts of the GDP guideline relevant to their activities, amongst others Chapter 9". EU competent supervisory authorities carry out GDP inspections (and issue GDP certificates) only of companies holding wholesale distribution authorisations or companies which are aiming for one. Some are also part of GMP inspections at pharmaceutical manufacturers.
Find out more in the FAQs on the European GDP Association website.
Related GMP News
12.05.2026European GDP Association Developments January through April 2026
12.05.2026How Are Service Providers Qualified in a GDP Environment?
12.05.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 3
11.05.2026European GDP Association Developments January through April 2026
21.04.2026Implementation of GDP for Pharmaceutical Products in Hong Kong
21.04.2026China's NMPA: Guiding Opinions & Q&A on Standardising Modern Pharmaceutical Logistics


